SOURCE: Xtalks

Xtalks Webinars

October 13, 2015 07:00 ET

Taking the Guesswork out of Feasibility Assessment in Oncology Clinical Trials, Live Webinar Hosted by Xtalks

Data Leads to Greater Predictability, Speed and Savings for Sponsors

TORONTO, ON--(Marketwired - October 13, 2015) - Many sponsors know first-hand the substantial costs of over estimating how quickly an oncology trial can be enrolled. From the operational costs of rescuing or extending a trial to the lost opportunity cost of delayed market entry, the financial ramifications can be astronomical if a sponsor gets the feasibility assessment of a trial wrong.

One might expect that enrollment would be one of the easier parts of the oncology research process. But despite the seriousness of a cancer diagnosis -- or perhaps because of it -- only three to five percent of adult patients with cancer participate in clinical trials. Under-enrollment is common and virtually all oncology drug sponsors face an uphill battle in patient recruitment.

If patient enrollment is difficult, forecasting patient enrollment is even more so. In general, the methods used to forecast enrollment have not been very accurate, and this is especially true in oncology trials.

This webinar will present an approach to forecasting enrollment in oncology trials and share a case study with predicted vs. actual results. Industry experts will share the methods and approaches developed in the feasibility phase of oncology trials conducted by inVentiv Health, a top-tier professional services organization that accelerates the clinical and commercial success of biopharmaceutical companies worldwide.

Learn from industry experts:

  • Robert Millham, Senior Vice President and General Manager of Hematology & Oncology
  • JB Flinders, Director of Feasibility & Clinical Informatics

The free one-hour live session takes place on Thursday, October 22, 2015 at 11am EDT / 4pm BST (UK/GMT+1).

inVentiv Health experts will share ideas for better trial predictability, shorter timelines and meaningful cost savings. Key topics that will be covered in the webinar will include:

  • The unique challenges in forecasting oncology trial enrollment
  • Best practices in identifying comparable trials for oncology benchmarking and planning
  • Key steps to ensure that forecasts are realistic and achievable
  • Pitfalls in traditional enrollment forecasting processes
  • New tools and data sources being used to plan oncology trials

To learn more or register for this event visit: Taking the Guesswork Out of Feasibility Assessment in Oncology Trials

About inVentiv Health

inVentiv Health is a top-tier professional services organization that accelerates the clinical and commercial success of biopharmaceutical companies worldwide. Our combined Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) help clients improve their performance to deliver much-needed therapies to market. With 14,000 employees providing services to clients in 70 countries, inVentiv Health designs best practices, processes and systems to enable clients to successfully navigate an increasingly complex environment. inVentiv Health, Inc. is privately owned by inVentiv Group Holdings, Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv Health management team. Learn more at

About Xtalks

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, health care centers, etc.) turn to Xtalks for access to quality content. Xtalks helps life science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

For information about hosting a webinar, visit

Image Available:

Contact Information